CNXC Stock Forecast & Price Target

Concentrix is attractive because its valuation is exceptionally low at under 4x EV/EBITDA on CY27E, alongside a free cash flow yield in the mid-40s to north of 50%, while management’s roughly $2B of projected free cash flow over the next three years exceeds today’s equity value. The outlook is strengthened by iX momentum, including 61 deployments covering 30,000+ advisors, record contract signings up 400% year-over-year in fiscal Q2/26, and revenue expected to grow 30%+ this year and exceed $6B in FY27 with retention about four times the traditional business. Balance-sheet repair also supports equity upside, as net debt fell to about $4.12B after $211M of debt reduction, is expected near $3.8B year-end, and management is prioritizing deleveraging and dividend growth over buybacks.

Concentrix is facing a deteriorating demand backdrop as revenue guidance was cut again, with FY26 now implying a 0.3%-0.8% constant-currency decline and Q4 guided to a 3%-5% drop after Q3 revenue fell 0.5% in constant currency. The weakness reflects shrinking support from two hyperscaler clients, faster AI-driven spending shifts, and persistent offshoring headwinds, while customer concentration, overseas delivery exposure, and macro volatility leave results vulnerable to further disruption. Even with Q4 non-GAAP operating income of $310-$320 million implying about a 12.9% margin and free cash flow of $209.7 million in fiscal Q2/26, adjusted EBITDA missed forecasts and leverage remained elevated at 3.0x net debt to TTM adjusted EBITDA.